SEC Form D filing

Goldenrod Therapeutics, Inc.

Biotech · Series A · Regulation D 506(b) · TX · Filed June 3, 2026

Offering amount

$6.5M

Exemption

Reg D 506(b)

Issuer state

Filing date

June 3, 2026

Signature date

June 3, 2026

CIK

0002127885

Summary

Auto-generated

biotech company, $6.5M Series A in TX

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.